According to Seema Srivastava, Senior Research Analyst at SMC Global Securities, the group’s Q3FY25 quarterly results reflected mixed performance across its subsidiaries.

It was about a year ago that shares of Iovance Biotherapeutics (NASDAQ: IOVA) began to take off. Could this be a great buying ...

The decline in ServiceNow’s share price comes in the wake of a "lackluster outlook" for 2025 subscription growth on a slower artificial intelligence sales bump," ...

Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Regular MarketWatch readers might already be aware that U.S. stocks are historically expensive right now, based on several ...

Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

IBM stock, with 45% returns since the beginning of 2024, has outperformed the S&P 500 index, up 27%. Strong demand trends for its software business has driven its stock price growth lately. But, if ...

U.S. stock futures point mostly higher as investors react to corporate earnings, Apple is slated to report results after the ...

With stock valuations climbing steadily over the past two years and artificial intelligence (AI) budgets of the big tech ...

Nvidia’s AI leadership remains intact, despite DeepSeek concerns. Read why NVDA stock’s steep drop represents a great ...

Rolls is currently our largest investment and we consider it is at an attractive valuation. Click here for our thesis on RYCEY stock.

The latest U.S. Federal Reserve meeting saw interest rates remain on hold as it seeks to make more progress on lowering ...